This is a multi-center and multi-national,randomized, double blind, placebo-controlled, 28-day treatment study with BAY 68-4986 taken orally or a matching placebo.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
1mg Capadenoson, double dummy
2mg Capadenoson, double dummy
4mg Capadenoson, double dummy
Unnamed facility
Brno, Czechia
Total exercise time
Time frame: 28 days for ETT and 42 days for safety
Time to angina onset
Time frame: 28 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Placebo, double dummy
Unnamed facility
Hodonín, Czechia
Unnamed facility
Kroměříž, Czechia
Unnamed facility
Olomouc, Czechia
Unnamed facility
Ostrava, Czechia
Unnamed facility
Pilsen, Czechia
Unnamed facility
Prague, Czechia
Unnamed facility
Prague, Czechia
Unnamed facility
Balatonfüred, Hungary
Unnamed facility
Kecskemét, Hungary
...and 26 more locations